672 filings
Page 3 of 34
ARS
lb25xmj6vbp
11 Apr 23
Annual report to shareholders
4:32pm
8-K
s3d4v hace
10 Mar 23
Regulation FD Disclosure
4:28pm
8-K
4jn3acbcb5c0fqz5pb2o
9 Mar 23
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
7:02am
8-K
vu8r98vn87 h8d05fpuz
6 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
CT ORDER
0cfrw63
22 Feb 23
Confidential treatment order
9:33am
UPLOAD
wy71oo
30 Jan 23
Letter from SEC
12:00am
CORRESP
2t43oh4tgpy
27 Jan 23
Correspondence with SEC
12:00am
CORRESP
3lud4qyc
6 Jan 23
Correspondence with SEC
12:00am
UPLOAD
dnc4xzyz
12 Dec 22
Letter from SEC
12:00am
CORRESP
khxlts5
5 Dec 22
Correspondence with SEC
12:00am
8-K
lyy6yiudyiosdx i0
9 Nov 22
Results of Operations and Financial Condition
4:59pm
8-K
4cynk6sunh996
9 Nov 22
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
9:33am
UPLOAD
x3hmfi 9q
1 Nov 22
Letter from SEC
12:00am
8-K
y5t4but11v85az
8 Aug 22
Results of Operations and Financial Condition
8:01am
8-K/A
qb6stxzoa7qw
8 Aug 22
Cost Associated with Exit or Disposal Activities
8:01am
8-K
sdv0l97tq67r
2 Jun 22
ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition
5:01pm